Research On Evaluation System And Method Of Internal Control Of Listed Companies Of China's Pharmaceutical Manufacturing

In2008, after Wall Street tsunami was caused by subprime mortgage crisis,many USA known enterprises got into troubles like bankruptcy protection or to beacquired, such as American Lehman brothers, Washington Mutual Bank, the worldCommunication Company and general motors. It aroused new reflection on theinternal control theory in both theory field and practice field, internal control istreated as an approach for enterprises to avoid risk, why these large corporations whoboast having a sound internal control will face the crisis of bankruptcy? Afterin-depth study, the experts came to two conclusions: one is that the internal controlevaluation criteria is apart from the actual situation and is inoperable by enterprises,so internal control cannot effectively guide the enterprises to practice; the other one iscorporate governance have flaws which make Internal control existed in name only.Under such background, the quality of internal control attracted the attention ofenterprises and scholars. A new round study of internal control evaluation betweenthe theory and practice begin.Based on the COSO report and China’s "basic norms of internal control", and onthe criterion of strengthening enterprise internal control system construction andcontrol for raising the level of standards, combining with the current situation ofinternal control, starting from the introduction of risk management theory, and deeplearning relative theories internal control on the basis of the "basic norms ofenterprise internal control--the enterprise internal control appraisal guidelines", thispaper is targeted to focus on the internal control evaluation in listed companies ofpharmaceutical manufacturing industry. This paper introduces the impact internalcontrol evaluation have on the theory of internal control in pharmaceuticalmanufacturing listed companies, engaging in strengthening pharmaceuticalmanufacturing system of internal control of listed Corporation with risk control as thecenter, and establishes the grey clustering assessment model for the pharmaceuticalmanufacturing to perform grade evaluation of internal control listed Corporation.Chapter1, introduction. It mainly introduces the research background,significance and literature review, and the main methods, the contents of the researchand ideas. Chapter2, theoretical research of Listed companies internal control evaluation. It maimed discusses the purpose and scope of internal control evaluation,and the methods to assess risk. With the purpose of deterging the principles ofan evaluation system of internal control，and to ensure reasonableness and effect of the internal control.Chapter3, establishment of internal control evaluation index system of manufacturing pharmaceutical listed Corporation. Through analysis present basic situation of pharmaceutical industry and its internal control, according to the pharmaceutical industry’s internal control risk to establish a reasonable pharmaceutical manufacturing internal control evaluation index system for listed Corporation.Chapter4, the principle of grey clustering assessment model. Mainly introducesthe grey system theory and background knowledge introduction to grey clusteringevaluation model, get ready for the data analysis of the case study.Chapter5, analysis the application of internal control evaluation in listedCorporations. Selected four representative different pharmaceutical manufacturinglisted Corporations of pharmaceutical manufacturing listed companies from theShanghai and Shenzhen, this paper test and verify the feasibility and validity of theindex.Chapter6, conclusions. Elaborates the conclusion and effect of internal controlrevaluation model constructed in this paper for listed companies especially forpharmaceutical manufacturing industry, gives relevant suggestions and points out thedeficiency and future trend.